Status:
UNKNOWN
Comparison of Quality of Life in Patients with Differentiated Thyroid Carcinoma Undergoing Different Surgery
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions:
Thyroid Cancer
Eligibility:
All Genders
18-70 years
Brief Summary
The incidence of thyroid cancer has increased rapidly in recent years, especially in women. Early differentiated thyroid cancer has a good prognosis, and surgery is the main treatment. Traditional ope...
Detailed Description
The incidence of thyroid cancer has increased rapidly in recent years, especially in women. Differentiated thyroid cancer takes the largest proportion in thyroid cancer, but it has a good prognosis. F...
Eligibility Criteria
Inclusion
- Age ≥18 years and \< 70 years;
- Biopsy or surgical pathology indicated differentiated thyroid carcinoma (papillary thyroid carcinoma, follicular carcinoma);
- stage T1\~T3a, N0\~N1a, M0;
- Ability to read and write Chinese;
- Willingness to follow up.
Exclusion
- Age \< 18 years old or ≥70 years old;
- Biopsy or surgical pathology indicated medullary carcinoma or anaplastic thyroid carcinoma;
- Aggressive histology: tall cell, columnar cell, hobnail variant, etc.
- Mixed with medullary carcinoma or anaplastic thyroid carcinoma;
- High risk of recurrence (according to ATA guideline);
- Lateral cervical lymph node metastasis or distant metastasis;
- Suffer from other malignant tumors;
- History of thyroid surgery or cervical lymph node dissection;
- Cognition or behavior impairment.
Key Trial Info
Start Date :
September 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 10 2025
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT06037174
Start Date
September 15 2023
End Date
September 10 2025
Last Update
October 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen Memorial Hopsital
Guangzhou, Guangdong, China, 510289